These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 14975604

  • 21. Analysis of a T-287C polymorphism in the tissue factor pathway inhibitor gene and identification of a repressor element in the promoter.
    Amini Nekoo A, Iles D.
    Thromb Res; 2008; 121(6):813-9. PubMed ID: 17931693
    [Abstract] [Full Text] [Related]

  • 22. A new genetic variant involved in genetic susceptibility to alcoholic liver cirrhosis: -330T>G polymorphism of the interleukin-2 gene.
    Marcos M, Pastor I, González-Sarmiento R, Laso FJ.
    Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):855-9. PubMed ID: 18794598
    [Abstract] [Full Text] [Related]

  • 23. Four novel single nucleotide polymorphisms within the promoter region of p53 gene and their associations with uterine leiomyoma.
    Hsieh YY, Wang JP, Lin CS.
    Mol Reprod Dev; 2007 Jul; 74(7):815-20. PubMed ID: 17186536
    [Abstract] [Full Text] [Related]

  • 24. SNPs upstream of the minimal promoter control IL-2 expression and are candidates for the autoimmune disease-susceptibility locus Aod2/Idd3/Eae3.
    del Rio R, Noubade R, Subramanian M, Saligrama N, Diehl S, Rincon M, Teuscher C.
    Genes Immun; 2008 Mar; 9(2):115-21. PubMed ID: 18200031
    [Abstract] [Full Text] [Related]

  • 25. [Association of the hepatic lipase gene -250G/A promoter polymorphism with the susceptibility to type 2 diabetes mellitus combining with coronary heart disease].
    Wei M, Lu YS, Li PP.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Apr; 26(2):219-22. PubMed ID: 19350521
    [Abstract] [Full Text] [Related]

  • 26. FcRL3 and multiple sclerosis pathogenesis: role in autoimmunity?
    Martínez A, Mas A, de Las Heras V, Bartolomé M, Arroyo R, Fernández-Arquero M, de la Concha EG, Urcelay E.
    J Neuroimmunol; 2007 Sep; 189(1-2):132-6. PubMed ID: 17617473
    [Abstract] [Full Text] [Related]

  • 27. The CTLA4 +49 A/G*G-CT60*G haplotype is associated with susceptibility to multiple sclerosis in Flanders.
    Suppiah V, Alloza I, Heggarty S, Goris A, Dubois B, Carton H, Vandenbroeck K.
    J Neuroimmunol; 2005 Jul; 164(1-2):148-53. PubMed ID: 15904974
    [Abstract] [Full Text] [Related]

  • 28. A novel functional polymorphism in the Cdc6 promoter is associated with the risk for hepatocellular carcinoma.
    Xiong XD, Fang JH, Qiu FE, Zhao J, Cheng J, Yuan Y, Li SP, Zhuang SM.
    Mutat Res; 2008 Aug 25; 643(1-2):70-4. PubMed ID: 18640135
    [Abstract] [Full Text] [Related]

  • 29. Identification of a novel 12-nucleotide insertion polymorphism in the promoter region of ADRA2B: full linkage with the 9-nucleotide deletion in the coding region and influence on transcriptional activity.
    Crassous PA, Blaise R, Marquette A, Snapir A, Scheinin M, Paris H, Schaak S.
    Biochem Pharmacol; 2010 Feb 01; 79(3):407-12. PubMed ID: 19728989
    [Abstract] [Full Text] [Related]

  • 30. [Polymorphism of regulated upon activation, normal T cell expressed and secreted promoter region -28 position in Chinese allergic asthmatic children].
    Wang LJ, Li YR, Chen JH, Cui TP, Wu JM.
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Jun 01; 27(6):394-7. PubMed ID: 15256089
    [Abstract] [Full Text] [Related]

  • 31. Pro- and anti-inflammatory cytokine gene polymorphism profiles in Bulgarian multiple sclerosis patients.
    Mihailova S, Ivanova M, Mihaylova A, Quin L, Mikova O, Naumova E.
    J Neuroimmunol; 2005 Nov 01; 168(1-2):138-43. PubMed ID: 16183136
    [Abstract] [Full Text] [Related]

  • 32. [Polymorphism of NOS2A promoter -969(G>C) is associated with portal hypertension of liver cirrhosis].
    Cheng YQ, Wang WQ, Lin JS, Xiong P, Jiang XD.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Dec 01; 21(6):591-5. PubMed ID: 15583989
    [Abstract] [Full Text] [Related]

  • 33. TNFalpha promoter polymorphisms.
    Fargion S, Valenti L, Dongiovanni P, Fracanzani AL.
    Methods Mol Med; 2004 Dec 01; 98():47-58. PubMed ID: 15064432
    [Abstract] [Full Text] [Related]

  • 34. Identification of functional genetic variants in cyclooxygenase-2 and their association with risk of esophageal cancer.
    Zhang X, Miao X, Tan W, Ning B, Liu Z, Hong Y, Song W, Guo Y, Zhang X, Shen Y, Qiang B, Kadlubar FF, Lin D.
    Gastroenterology; 2005 Aug 01; 129(2):565-76. PubMed ID: 16083713
    [Abstract] [Full Text] [Related]

  • 35. The mouse chemerin receptor gene, mcmklr1, utilizes alternative promoters for transcription and is regulated by all-trans retinoic acid.
    Mårtensson UE, Bristulf J, Owman C, Olde B.
    Gene; 2005 Apr 25; 350(1):65-77. PubMed ID: 15792532
    [Abstract] [Full Text] [Related]

  • 36. Promoter polymorphisms of IL2, IL4, and risk of gastric cancer in a high-risk Chinese population.
    Wu J, Lu Y, Ding YB, Ke Q, Hu ZB, Yan ZG, Xue Y, Zhou Y, Hua ZL, Shu YQ, Liu P, Shen J, Xu YC, Shen HB.
    Mol Carcinog; 2009 Jul 25; 48(7):626-32. PubMed ID: 19058298
    [Abstract] [Full Text] [Related]

  • 37. Tumor necrosis factor-alpha promoter polymorphism is associated with susceptibility to oral squamous cell carcinoma.
    Liu CJ, Wong YK, Chang KW, Chang HC, Liu HF, Lee YJ.
    J Oral Pathol Med; 2005 Nov 25; 34(10):608-12. PubMed ID: 16202081
    [Abstract] [Full Text] [Related]

  • 38. Transcriptional regulation of MICA and MICB: a novel polymorphism in MICB promoter alters transcriptional regulation by Sp1.
    Rodríguez-Rodero S, González S, Rodrigo L, Fernández-Morera JL, Martínez-Borra J, López-Vázquez A, López-Larrea C.
    Eur J Immunol; 2007 Jul 25; 37(7):1938-53. PubMed ID: 17557375
    [Abstract] [Full Text] [Related]

  • 39. TNF-related apoptosis inducing ligand (TRAIL) gene polymorphism in Japanese patients with multiple sclerosis.
    Kikuchi S, Miyagishi R, Fukazawa T, Yabe I, Miyazaki Y, Sasaki H.
    J Neuroimmunol; 2005 Oct 25; 167(1-2):170-4. PubMed ID: 16040132
    [Abstract] [Full Text] [Related]

  • 40. CRYAB promoter polymorphisms: influence on multiple sclerosis susceptibility and clinical presentation.
    Stoevring B, Frederiksen JL, Christiansen M.
    Clin Chim Acta; 2007 Jan 25; 375(1-2):57-62. PubMed ID: 17010329
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.